(Q38543455)

4 September 2017

1 reference

title

Global epidemiology of gout: prevalence, incidence and risk factors (English)

1 reference

4 September 2017

1 reference

Matthew J Grainge

2

0 references

Weiya Zhang

object named as

Weiya Zhang

series ordinal

3

0 references

Michael Doherty

object named as

Michael Doherty

series ordinal

4

0 references

author name string

Chang-Fu Kuo

series ordinal

1

1 reference

PubMed ID

26150127

4 September 2017

language of work or name

English

0 references

publication date

7 July 2015

1 reference

Nature Reviews Rheumatology

4 September 2017

1 reference

4 September 2017

11

1 reference

4 September 2017

11

1 reference

4 September 2017

649-662

1 reference

https://scigraph.springernature.com/pub.10.1038/nrrheum.2015.91

4 September 2017

0 references

cites work

Comorbidities in patients with gout prior to and following diagnosis: case-control study

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Hyperuricemia, gout and the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Gout and coronary heart disease: the Framingham Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Gout and the risk of acute myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Risk of myocardial infarction among patients with gout: a nationwide population-based study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Risk of end-stage renal disease associated with gout: a nationwide population study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Epidemiology: Gout--bad for the heart as well as the joint

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

The changing epidemiology of gout

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Gout: why is this curable disease so seldom cured?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

The epidemiology of hyperuricaemia and gout in Taiwan aborigines.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Prevalence of gout with comorbidity aggregations in southern Taiwan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

A SURGERY OF RHEUMATISM IN A RURAL NEW ZEALAND MAORI COMMUNITY.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

A prospective study of gout in New Zealand Maoris

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Gout is on the increase in New Zealand

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Gout in French Polynesia: a survey of common practices

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Prevalence of musculoskeletal diseases in Guatemala, Central America: the COPCORD study of 2 populations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Prevalence of musculoskeletal disorders in southeastern Iran: a WHO-ILAR COPCORD study (stage 1, urban study).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

WHO-ILAR COPCORD study (stage 1, urban study) in Sanandaj, Iran.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Effect of ethnic origin (Caucasians versus Turks) on the prevalence of rheumatic diseases: a WHO-ILAR COPCORD urban study in Iran.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Hyperuricemia in Saudi Arabia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

The prevalences of some rheumatic diseases in western Turkey: Havsa study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Serum uric acid concentrations in a Xhosa community in the Transkei of Southern Africa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Chronic inflammatory rheumatic diseases in black Zimbabweans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Determinants of the prevalence of gout in the general population: a systematic review and meta-regression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

The prevalence of rheumatic diseases in central Greece: a population survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Resource use and economic impact of patients with gout: a multicenter, population-wide study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Prevalence of self reported musculoskeletal diseases is high

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

National prevalence of gout derived from administrative health data in Aotearoa New Zealand

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Familial aggregation of gout and relative genetic and environmental contributions: a nationwide population study in Taiwan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Gout and hyperuricaemia in rural and urban populations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Gout epidemiology: results from the UK General Practice Research Database, 1990-1999.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Systematic review of the prevalence of gout and hyperuricaemia in Australia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Epidemiology and management of gout in Taiwan: a nationwide population study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Burden and control of musculoskeletal conditions in developing countries: a joint WHO/ILAR/BJD meeting report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Community-based study to estimate prevalence and burden of illness of rheumatic diseases in Cuba: a COPCORD study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Prevalence of musculoskeletal disorders and rheumatic diseases in an urban community in Monagas State, Venezuela: a COPCORD study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Prevalence of the major rheumatic disorders in the adult population of north Pakistan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Low back pain in hospital outpatients in Lomé (Togo).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Hyperuricaemia and Gout in the Mariana Islands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Hyperuricaemia, gout, and diabetic abnormality in Polynesian people.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

High prevalence of hyperuricaemia and gout in an urbanised Micronesian population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Hyperuricaemia and gout in Western Samoans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Gout in a New England town. A prevalence study in Sudbury, Massachusetts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Review of UK data on the rheumatic diseases--4. Gout

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Seasonality and trends in the incidence and prevalence of gout in England and Wales 1994-2007.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Epidemiology of gout and hyperuricemia. A long-term population study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Factors affecting urate solubility in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Serum uric acid in 23,923 men and gout in a subsample of 4257 men in France

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Clinical and family studies in Hungarian patients with gout

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Heredity of gout and hyperuricemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

31 March 2020

Heredity in primary gout

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Heredity in gout and hyperuricemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Clinical survey of 354 patients with gout

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

THE GENETICS OF GOUT AND HYPERURICEMIA-AN ANALYSIS OF NINETEEN FAMILIES.

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

31 March 2020

12 December 2020

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

1 reference

UROMODULIN mutations cause familial juvenile hyperuricemic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Genome-wide association analyses identify 18 new loci associated with serum urate concentrations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Twenty-eight loci that influence serum urate levels: analysis of association with gout.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Heterogeneity in the familial aggregation of fasting serum uric acid level in five North American populations: the Lipid Research Clinics Family Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Genome scan for determinants of serum uric acid variability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Segregation analysis of serum uric acid in the NHLBI Family Heart Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Menopause, postmenopausal hormone use and risk of incident gout

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Drinking and its relation to smoking, BP, blood lipids, and uric acid. The Framingham study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Purine-rich foods, dairy and protein intake, and the risk of gout in men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Alcohol intake and risk of incident gout in men: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Fructose-induced hyperuricaemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Coffee consumption and risk of incident gout in men: a prospective study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Cherry consumption and decreased risk of recurrent gout attacks

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Vitamin C intake and the risk of gout in men: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Incident gout in women and association with obesity in the Atherosclerosis Risk in Communities (ARIC) Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

The prevalence of metabolic syndrome in patients with gout: a multicenter study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Contemporary epidemiology of gout in the UK general population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Predictors of new-onset decline in kidney function in a general middle-european population.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Elevated uric acid increases the risk for kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Chronic kidney disease and the risk of incident gout among middle-aged men: a seven-year prospective observational study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Serum uric acid and adiposity: deciphering causality using a bidirectional Mendelian randomization approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Psoriasis, psoriatic arthritis and risk of gout in US men and women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Gout and hyperuricemia associated with sickle-cell Anemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Anemia and the onset of gout in a population-based cohort of adults: Atherosclerosis Risk in Communities study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Gouty arthritis in chronic obstructive pulmonary disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Some observations on 520 gouty patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Gout and hypothyroidism in males

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

The prevalence of hypothyroidism in gout

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Hyperthyroid and hypothyroid status was strongly associated with gout and weakly associated with hyperuricaemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

The renal manifestations of thyroid disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Use of diuretics and risk of incident gout: a population-based case-control study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

A urate gene-by-diuretic interaction and gout risk in participants with hypertension: results from the ARIC study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Cyclosporine-induced hyperuricemia and gout

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Gout in solid organ transplantation: a challenging clinical problem

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Uric acid transport and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Low-dose aspirin use and recurrent gout attacks

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Long-term efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in hyperlipidaemic patients with diabetes or metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Development of acute gout secondary to pyrazinamide in a patient without a prior history of gout

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Environmental lead exposure and urate excretion in the general population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Low-level lead exposure and the prevalence of gout: an observational study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

The crystallization of monosodium urate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Growth of monosodium urate monohydrate crystals: effect of cartilage and synovial fluid components on in vitro growth rates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Nucleation of monosodium urate crystals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

The effect of lead upon urate nucleation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Enhancement of urate solubility by connective tissue. I. Effect of proteoglycan aggregates and buffer cation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Orderly arrayed deposit of urate crystals in gout suggest epitaxial formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

The Pathogenesis of Podagra

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Purine-rich foods intake and recurrent gout attacks

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Alcohol quantity and type on risk of recurrent gout attacks: an internet-based case-crossover study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Coffee consumption and risk of incident gout in women: the Nurses' Health Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Incidence and risk factors for gout in white men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Racial differences in the incidence of gout. The role of hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Gout in African Americans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Prevalence and incidence of the diagnosis of gout in Great Britain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Incidence of Inflammatory Rheumatic Diseases in Finland

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Alcohol consumption as a trigger of recurrent gout attacks.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

A case-control study of the association of diet and obesity with gout in Taiwan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Preliminary criteria for the classification of the acute arthritis of primary gout

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Clinical diagnostic criteria for gout: comparison with the gold standard of synovial fluid crystal analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Validity of gout diagnoses in administrative data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Quality of care for gout in the US needs improvement

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Omeprazole, other antiulcer drugs and newly diagnosed gout

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Toward a valid definition of gout flare: results of consensus exercises using Delphi methodology and cognitive mapping.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2015.91

Trends in hyperuricemia and gout prevalence: Nutrition and Health Survey in Taiwan from 1993-1996 to 2005-2008.

31 March 2020

1 reference

12 December 2020

Gout secondary to pyrazinamide and ethambutol.

1 reference

12 December 2020

Musculoskeletal pain in Malaysia: a COPCORD survey

1 reference

12 December 2020

Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002-2003.

1 reference

12 December 2020

Rheumatic disease in an Australian Aboriginal community in North Queensland, Australia. A WHO-ILAR COPCORD survey

1 reference

12 December 2020

Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China.

1 reference

12 December 2020

Prevalence of the rheumatic diseases in urban Vietnam: a WHO-ILAR COPCORD study

1 reference

12 December 2020

The prevalence of rheumatic diseases in a Filipino urban population: a WHO-ILAR COPCORD Study. World Health Organization. International League of Associations for Rheumatology. Community Oriented Programme for the Control of the Rheumatic Diseases

1 reference

12 December 2020

Community based study to estimate prevalence, burden of illness and help seeking behavior in rheumatic diseases in Mexico City. A COPCORD study

1 reference

12 December 2020

Risk factors for gout in Togolese patients

1 reference

12 December 2020

Two epidemics of gout.

1 reference

12 December 2020

The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China.

1 reference

12 December 2020

Prevalence of self-reported rheumatic diseases in a Portuguese population

1 reference

12 December 2020

WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran.

1 reference

12 December 2020

Effect of low level lead exposure on hyperuricemia and gout among middle aged and elderly men: the normative aging study.

1 reference

12 December 2020

Epidemiology of rheumatic disease in rural Thailand: a WHO-ILAR COPCORD study. Community Oriented Programme for the Control of Rheumatic Disease

1 reference

12 December 2020

[Incidence and various risk factors for gout in the Georgian SSR]

1 reference

12 December 2020

Migration and gout: the Tokelau Island migrant study

1 reference

12 December 2020

The epidemiology study of hyperuricemia and gout in a community population of Huangpu District in Shanghai.

1 reference

12 December 2020

Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study

1 reference

12 December 2020

Rheumatic disorders in the South African Negro. Part IV. Gout and hyperuricaemia

1 reference

12 December 2020

High prevalence of gout and related risk factors in Taiwan's Aborigines.

1 reference

12 December 2020

Prevalence of rheumatic diseases in a rural population in western India: a WHO-ILAR COPCORD Study

1 reference

12 December 2020

The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study.

1 reference

12 December 2020

Gout and Hyperuricemia in a Finnish Rural Population

1 reference

12 December 2020

The epidemiology of gout and hyperuricemia in a rural population of Java

1 reference

12 December 2020

The genetics of gout and hyperuricaemia

1 reference

12 December 2020

Epidemiology of gout: is the incidence rising?

1 reference

12 December 2020

Population Studies of Serum Uric Acid

1 reference

12 December 2020

Hyperuricemia and gout in Taiwan: results from the Nutritional and Health Survey in Taiwan (1993-96).

1 reference

12 December 2020

Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China: a COPCORD study

1 reference

12 December 2020

Primary gout in Shantou: a clinical and epidemiological study.

1 reference

12 December 2020

Is ritonavir boosting associated with gout?

1 reference

12 December 2020

Community based epidemiological study on hyperuricemia and gout in Kin-Hu, Kinmen

1 reference

12 December 2020

Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2015.91

1 reference

PubMed ID

26150127

Dimensions Publication ID

4 September 2017

0 references

1 reference

PubMed ID

26150127